AMCP Partnership Forum: New Specialty Medication Benefit and Reimbursement Designs
One of the biggest challenges facing patients and payers is the rising cost of specialty drugs including gene therapies and [...]
Article: U.S. Should Scrap Specialty Drug Label
The U.S. should abandon the specialty-drug label for high-cost drugs and follow suit with other countries that categorize drugs by [...]
Article Outlines How Health Plans Utilize RWE for Specialty Drug Coverage
Health plans' use of real-world evidence for specialty drug coverage decisions is generally varied in terms of the number and [...]
Advertisement
